nsv7097611
- Organism: Homo sapiens
- Study:nstd102 (Clinical Structural Variants)
- Variant Type:copy number variation
- Method Type:Multiple
- Submitted on:GRCh37
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: Yes
- Region Size:438,363
- Description:NC_000007.13:g.(?_144094333)_(144532695_?)del AND Childhood encephalopathy due to thiamine pyrophosphokinase deficiency
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 1166 SVs from 79 studies. See in: genome view
Overlapping variant regions from other studies: 401 SVs from 31 studies. See in: genome view
Overlapping variant regions from other studies: 1166 SVs from 79 studies. See in: genome view
Variant Region Placement Information
Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Inner Start | Inner Stop |
---|---|---|---|---|---|---|---|---|---|
nsv7097611 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000007.14 | Chr7 | 144,397,240 | 144,835,602 |
nsv7097611 | Remapped | Pass | GRCh38.p12 | PATCHES | Second Pass | NW_018654715.1 | Chr7|NW_01 8654715.1 | 446,707 | 680,662 |
nsv7097611 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000007.13 | Chr7 | 144,094,333 | 144,532,695 |
Variant Call Information
Variant Call ID | Type | Method | Analysis | Subject Phenotype | Clinical Interpretation | Source of Interpretation | ClinVar ID |
---|---|---|---|---|---|---|---|
nssv18789447 | deletion | Multiple | Multiple | Childhood encephalopathy due to thiamine pyrophosphokinase deficiency; THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE); THMD5; Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type) | Pathogenic | ClinVar | RCV003111492.2, VCV002426756.3 |
Variant Call Placement Information
Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Inner Start | Inner Stop |
---|---|---|---|---|---|---|---|---|---|
nssv18789447 | Remapped | Pass | NW_018654715.1:g.( ?_446707)_(680662_ ?)del | GRCh38.p12 | Second Pass | NW_018654715.1 | Chr7|NW_01 8654715.1 | 446,707 | 680,662 |
nssv18789447 | Remapped | Perfect | NC_000007.14:g.(?_ 144397240)_(144835 602_?)del | GRCh38.p12 | First Pass | NC_000007.14 | Chr7 | 144,397,240 | 144,835,602 |
nssv18789447 | Submitted genomic | NC_000007.13:g.(?_ 144094333)_(144532 695_?)del | GRCh37 (hg19) | NC_000007.13 | Chr7 | 144,094,333 | 144,532,695 |
No validation data were submitted for this variant
Clinical Assertions
Variant Call ID | HGVS | Type | Allele Origin | Subject Phenotype | Clinical Interpretation | Source of Interpretation | ClinVar ID |
---|---|---|---|---|---|---|---|
nssv18789447 | GRCh37: NC_000007.13:g.(?_144094333)_(144532695_?)del | deletion | germline | Childhood encephalopathy due to thiamine pyrophosphokinase deficiency; THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE); THMD5; Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type) | Pathogenic | ClinVar | RCV003111492.2, VCV002426756.3 |